Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
05-2020 | 02-2020 | 11-2019 | 08-2019 | 05-2019 | |
Operating Expenses | 951 | 1,371 | 1,336 | 0 | 941 |
Operating Income | -951 | -1,371 | -1,336 | N/A | -941 |
Other Income | 0 | 0 | 30 | 0 | 596 |
Pre-tax Income | -951 | -1,370 | -1,306 | 0 | -345 |
Net Income Continuous | -951 | -1,370 | -1,306 | N/A | -345 |
Net Income | $-951 | $-1,370 | $-1,306 | $N/A | $-345 |
EPS Basic Total Ops | -4.05 | -6.00 | -5.85 | N/A | -2.55 |
EPS Basic Continuous Ops | -4.11 | -6.00 | -5.83 | N/A | -2.51 |
EPS Diluted Total Ops | -4.05 | -6.00 | -5.85 | N/A | -2.55 |
EPS Diluted Continuous Ops | -4.11 | -6.00 | -5.83 | N/A | -2.51 |
EBITDA(a) | $-951 | $-1,370 | $-1,336 | $N/A | $-941 |